The company’s principal activities are design, develop and deliver of cybersecurity and smart robust solutions for drone, robotics and autonomous platforms.

The Company is an end-to-end provider of cybersecurity and robust solutions for drones, robotics & autonomous platforms. As a high-tech company it designs, develops, and delivers robust solutions focused primarily on targeting global drone, robotics and autonomous system manufacturers. The Company holds patented technology & unique know-how for Mobile Mesh networking. It has a large, field proven portfolio of commercialized products used in a variety of applications. The Company is growing a global customer base with sales to high profile customers including corporates, governments, and military departments. The Company’s competitive advantages include outstanding security capabilities and performance in harsh environmental conditions. The Company’s large solution portfolio is being deployed worldwide, seeing the Company derive revenue from hardware, software sales& licensing fees

In recent years, Israel has been engaged in sporadic armed conflicts with Hamas, an Islamist terrorist group that controls the Gaza Strip, with Hezbollah, an Islamist terrorist group that controls large portions of southern Lebanon, and with Iranian-backed military forces in Syria. In addition, Iran has threatened to attack Israel and may be developing nuclear weapons. Iran is also believed to have a strong influence among extremist groups in the region, such as Hamas in Gaza, Hezbollah in Lebanon, the Houthi movement in Yemen and various rebel militia groups in Syria and Iraq. On October 7, 2023, Hamas launched a series of attacks on civilian and military targets in Southern Israel and Central Israel, to which the Israel Defense Forces responded. On October 9, 2025, Israel, Hamas, the United States and other countries in the region agreed to a framework for a ceasefire in Gaza between Israel and Hamas. In addition, both Hezbollah and the Houthi movement attacked military and civilian targets in Israel, to which Israel responded, including through increased air and ground operations in Lebanon. In addition, the Houthi movement attacked international shipping lanes in the Red Sea, to which both Israel and the United States responded. While a ceasefire was brokered between Israel and Hezbollah in November 2024, in March 2026, hostilities resumed along Israel's northern border with Lebanon, when Hezbollah resumed its attacks as part of a broader regional escalation. In response, Israel resumed military operations against Hezbollah in Lebanon. Further, in April 2024 and October 2024, Iran launched a series of drone and missile strikes against Israel, to which Israel responded. In addition, in response to ongoing Iranian aggression and support of proxy attacks against Israel, on June 13, 2025, Israel conducted a series of preemptive defensive air strikes in Iran targeting Iran's nuclear program and military commanders. While a ceasefire was reached in June 2025 following 12 days of hostilities, on February 28, 2026, the United States and Israel launched coordinated military strikes against Iran, including attacks on strategic military infrastructure and leadership targets, with the stated aim of degrading Iran's capacity to conduct or support hostile operations against them. In response, Iran has fired missiles and drones toward population centers and military installations in Israel, Europe and neighboring countries in the Gulf region, and also launched counter-strikes against U.S. forces and allied bases throughout the Gulf region. Although the United States and Iran have announced ceasefire and de-escalation arrangements from time to time, including a memorandum of understanding entered into on June 17, 2026 that contemplates the termination of military operations on multiple fronts, hostilities have resumed and may continue or escalate. A broader regional conflict involving additional state and non-state actors remains a significant risk. How long and how severe the conflicts in Gaza, Northern Israel, Lebanon, Iran or the broader region last and become is unknown at this time, and any renewed or continued clash among Israel, Hamas, Hezbollah, Iran or other countries or militant groups in the region may escalate in the future into a greater regional conflict. Continued military escalation, retaliatory actions or broader regional involvement may adversely affect economic conditions, disrupt markets and create uncertainty that could negatively impact the Company's business, financial condition and results of operations. Certain of the Company's employees may be obligated to perform military reserve duty, generally until they reach the age of 40 (or older, for officers or other citizens who hold certain positions in the Israeli armed forces reserves), and, in the event of a military conflict, may be called to active duty. In response to increases in terrorist activity and military conflicts in Israel, there have been periods of significant call-ups of military reservists. Military service call-ups that result in the absence of Company personnel for an extended period of time may materially and adversely affect the Company's business, prospects, financial condition and results of operations.

The consolidated condensed interim unaudited financial statements were authorised for issue, in accordance with a resolution of directors, on August 13, 2026.

In addition, on January 30, 2024, in a concurrent private placement, the Company issued to the investors in the registered direct offering warrants to purchase up to an aggregate of 1,903,225 ADS at an exercise price of $1.55 per ADS. The warrants have 5-year term, and they can be exercised any time before expiry date January 30, 2029. The warrants may be exercised on a cashless basis if there is no effective registration statement registering the ADSs underlying the warrants.

In addition, on January 30, 2024, in connection with the registered direct offering, the Company granted a total 95,161 placement agent warrants each exercisable into one ADS at an exercise price of $1.55. The placement agent warrants have 5-year term, and they can be exercised any time before expiry date January 30, 2029. The placement agent warrants may be exercised on a cashless basis if there is no effective registration statement registering the ADSs underlying the warrants.

The pre-funded warrants, private placement warrants, and placement agent warrant are referred herein together as “January 2024 Warrants”. The January 2024 Warrants represent financial liabilities at fair value through profit or loss.

As of December 31, 2025, January 2024 Warrants were fully exercised.

For the half-year ended June 30, 2026, and 2025, the Company recorded fair value gain, net of $nil and $1,257,251, respectively, under the unaudited interim condensed consolidated statement of profit or loss and other comprehensive income as a result of the change in the fair value of January 2024 Warrants.

On a show of hands every member present at a meeting in person or by proxy shall have one vote and upon a poll each share shall have one vote.

Transition from ADS to listed Ordinary share

On August 25, 2022, the Company completed its Nasdaq listing via issuance of ADSs (American Depository Shares) with one ADS represents 275 ordinary shares in the Company. On December 8, 2025, the Company effected the Reverse Split and Mandatory Exchange, and the Company’s ordinary shares, which had been approved for listing and trading on the Nasdaq Capital Market, commenced trading at the market open on December 8, 2025.

Employee Incentive Options

On February 15, 2025, the board of directors of the Company approved grant of 262,727* options and 130,000* RSUs to employees, directors and consultants of the Company.

The options have an exercise price of $1.375 per share and expire on February 15, 2030.

123,636 options vest over a period of 3 years from the applicable vesting start dates. 139,091 options vest over a period of 4 years from the applicable vesting start dates.

On August 21, 2025, the Company issued 40,000* options to its employees, which vest over a period of 4 years from the applicable vesting start dates. The options have an exercise price of $2.984 per share and expire on August 21, 2030.

On December 1, 2025, the Company issued 1,279,999* options to its employees, directors and consultants.

The options have an exercise price of $5.9 per share and expire on December 1, 2030.

1,080,000 options vest over a period of 18 months from the applicable vesting start date. 140,000 options vest over a period of 3 years from the applicable vesting start dates and 59,999 options vests over a period of 4 years from the applicable vesting start dates.

The Company recognized share-based compensation expense of $ 3,112,346 for the six months period ended June 30, 2026 (June 30, 2025: $ 235,835) in relation to the vesting options.

Restricted Share Units (“RSUs”)

On February 15, 2025, the Company issued 130,000* RSUs to its employees and directors, which vest over a period of three years from the date of grant. The RSUs have no expiration date.

On June 26, 2025, the Company issued 904,308* RSUs to its directors, of which 452,154 vested on August 31, 2025, with the remaining 452,154 vesting through December 31, 2025. The RSUs have no expiration date.

On December 1, 2025, the Company issued 760,000* RSUs to its employees and directors. Of these RSUs, 720,000 vest in equal quarterly installments over an 18-month period commencing on January 1, 2026, 20,000 vest in equal quarterly installments over a three-year period commencing on August 1, 2026, and the remaining 20,000 vest in equal quarterly installments over a three-year period commencing on August 1, 2026.

The RSUs have no expiration date.